[Pharmacoeconomical aspects of the use of beta-blockers in hypertension and heart failure].
Ostroumova
O D
OD
Mamaev
V I
VI
Ishchenko
K A
KA
Shorikova
E G
EG
D000319:Adrenergic beta-Antagonists / Q000191:economics* / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000191:economics* / Q000627:therapeutic use*; D003365:Costs and Cost Analysis; D017850:Economics, Pharmaceutical; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000191:economics; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D012307:Risk Factors; D012959:Socioeconomic Factors
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents